The US expansion of federal funding for human embryonic stem-cell research is being hampered by details in consent forms.
Earlier this month, researchers celebrated the government's approval of funding for a broad variety of work on 13 stem-cell lines -the first approved under the policy announced by US President Barack Obama in March.
But on 14 December, Francis Collins, director of the National Institutes of Health (NIH) in Bethesda, Maryland, decided to respect the unanimous opinion of his standing advisory committee and restrict NIH funding for an additional 27 lines to purposes outlined in the associated consent form. He has as yet declined to discuss his reasoning.
The forms signed by the donating couples stipulated that cells derived from the embryos "will be used to study the embryonic development of endoderm with a focus on pancreatic formation" with the longterm goal of diabetes treatment. Collins 
